Do you experience spasticity associated with Multiple Sclerosis?
We are looking for volunteers with MS spasticity to take part in this trial.
Thank you for your interest! This trial no longer recruiting- please register with us to keep up to date with all our future trials!Register your interest in this clinical trial
We are carrying out an important clinical trial of a new treatment for people with Multiple Sclerosis related spasticity. Spasticity is a symptom of MS that causes your muscles to
feel stiff, heavy and difficult to move, as well as spasms.
To be eligible for this trial you need to be:
- You are aged between 18 and 70 (inclusive)
- You have a confirmed diagnosis of MS: relapsing remitting MS (RRMS), secondary progressive MS (SPMS) or primary progressive MS (PPMS)
- You have experienced spasticity for a minimum of 3 months
- You are not currently taking any medication for spasticity
- Are able to walk 20 metres unassisted or with a walking aid
- We cannot promise the study will help you but the information we get might help improve
the treatment of people with MS and the management of spasticity.
- This study is taking place at Croydon University Hospital in South London.
- In total there will be 12 scheduled visits to our unit and participation in the study will last approximately 72 days (10 weeks and 2 days).
- Travel expenses can be reimbursed throughout the trial and we can provide overnight accommodation during consecutive visits if required.
In recognition of your time involved in this study you will receive Â£1,215 and all your travel needs will be organised by us.
Speak to our Volunteer Recruitment team
Email: email@example.com for detailsRegister for this clinical trial
Call us: weekdays between 09h00 and 17h00 on +44 (0) 208 664 5200
(choose option 1) to speak to a member of our Volunteer Recruitment team.
Ref: CN1_OCT 2015 (email_website_advert text)
This advertisement has been approved by an ethics committee and any response to this advert will be recorded but you will not be under any obligation to participate in the trial.
The contents of this advert have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.
You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.